论文部分内容阅读
目的:探究双歧杆菌三联活菌肠溶胶囊+蒙脱石散治疗小儿腹泻的临床疗效。方法:择取该院2014年5月至2015年10月收治的急性腹泻患儿120例设置为本次的观察对象,按照随机数字表法进行分组,共分为常规组与实验组两组,每组患儿均占据60例。对常规组患儿单纯采取蒙脱石散治疗,而实验组患儿在此基础上加用适量的双歧杆菌三联活菌肠溶胶囊治疗,比较两种方案的治疗效果。结果:实验组与常规组患儿的治疗总有效率分别为95.0%与75.0%,比较差异显著(P<0.05);且实验组患儿临床各项症状的消失时间均明显短于常规组(P<0.05)。结论:对急性腹泻患儿采取双歧杆菌三联活菌肠溶胶囊+蒙脱石散治疗的疗效十分显著,可利于患儿疾病的早日康复。
Objective: To investigate the clinical efficacy of live bifidobacterium triple enteric-coated enteric-coated capsules + montmorillonite powder in the treatment of infantile diarrhea. Methods: A total of 120 children with acute diarrhea admitted to our hospital from May 2014 to October 2015 were enrolled in this study. According to the random number table method, 120 children were divided into two groups: conventional group and experimental group. Each group of children accounted for 60 cases. The conventional group of children simply treated with montmorillonite, while the experimental group children on the basis of the use of appropriate amount of Bifidobacterium triple live bacteria enteric-coated capsules, the treatment of two programs were compared. Results: The total effective rates of treatment group and conventional group were 95.0% and 75.0%, respectively (P <0.05), and the disappearance time of clinical symptoms in experimental group was significantly shorter than that in routine group P <0.05). Conclusion: The effect of taking Bifidobacterium triple viable enteric-coated enteric-coated capsules and montmorillonite powder in children with acute diarrhea is very significant, which can benefit the early rehabilitation of children’s diseases.